Trial Details
COMPLETEDBasic Information
| Clinical ID | c585 |
|---|---|
| Identifier | NCT03531892 |
| Trial Title | A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: AJM300|DRUG: Placebo |
Participant Information
| Sponsor | EA Pharma Co., Ltd. |
|---|---|
| City | Nagoya |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-06-06 |
|---|---|
| Primary Completion Date | 2020-11-09 |
| Completion Date | 2023-03-28 |